Open AccessEarly use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria
Author(s) -
Pedro SánchezRovira,
Gerardo Pérez-Chica,
A.L. Ortega Granados,
Josefa Aguilar-García,
Leticia Díaz-Beltrán,
Fernando Gálvez-Montosa,
Francisco García-Verdejo,
Natalia LuqueCaro,
Cristina Quero-Blanco,
Mónica Fernández-Navarro,
Agustín Rodríguez-Sánchez,
Manuel Ruiz-Bailén,
Luis Yaguez-Mateos,
Juan Francisco Marín-Pozo,
María Isabel Sierra-Torres,
Celia Lacárcel-Bautista,
Gaspar Jesús Duro-Ruiz,
María Ángeles Duro-Fernández,
Javier GarcíaAlegría,
Carmen HerreroRodríguez
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000026533
Subject(s) - tocilizumab , medicine , pneumonia , retrospective cohort study , cytokine storm , disease , covid-19 , infectious disease (medical specialty)